« Back
Home /
Topiroxostat

Topiroxostat

Item no.	TMO-T2397-2mg
Manufacturer	TargetMol
CASRN	577778-58-6
Amount	2 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category	Oncology By Cell Type Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Sato T, et al. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6225-9.
Smiles	N#Cc1cc(ccn1)-c1nc(n[nH]1)-c1ccncc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	FYX-051
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Cytochromes P450\|\|\|ROS\|\|\|Xanthine Oxidase
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	248.24
Description	Topiroxostat (FYX-051) is a selective xanthine oxidase inhibitor developed for the treatment and management of hyperuricemia and gout.
Pathways	Metabolism\|\|\|Immunology/Inflammation
Bioactivity	Topiroxostat(FYX-051) is a novel and potent xanthine oxidoreductase (XOR) inhibitor with IC50 value of 5.3 nM.
Receptor	XO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T2397-2mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 2 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question